Literature DB >> 33145996

miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma.

Liang Liang1,2, Zheng Yang1, Qian Deng3,4, Yazhuo Jiang3,4, Yongyi Cheng3,4, Yi Sun3,4, Lei Li1.   

Abstract

Previous reports have shown that miR-30d-5p functions as a tumor suppressor in prostate cancer and gallbladder carcinoma, but its role in renal cell carcinoma (RCC) remains elusive. This study was designed to explore the functional role of miR-30d-5p in proliferation and autophagy of RCC. Our results show that miR-30d-5p is significantly down-regulated in RCC tissues compared with normal tissues. miR-30d-5p overexpression suppressed cell proliferation, cell-cycle G1/S transition and autophagy, but promoted apoptosis in RCC cell lines (786-O and ACHN). Intriguingly, autophagy-related gene 5 (ATG5) was directly targeted by miR-30d-5p, as shown using luciferase reporter assay and biotin-avidin pull-down assay. Moreover, overexpression of ATG5 attenuated the inhibitory effect of miR-30d-5p on proliferation and autophagy in 786-O cells. These results suggest that miR-30d-5p suppresses proliferation and autophagy in RCC cells by targeting ATG5, and this pathway may be a suitable basis for the design of novel cancer therapeutics.
© 2020 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  ATG5; autophagy; miR-30d-5p; proliferation; renal cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 33145996      PMCID: PMC7876493          DOI: 10.1002/2211-5463.13025

Source DB:  PubMed          Journal:  FEBS Open Bio        ISSN: 2211-5463            Impact factor:   2.792


  36 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer.

Authors:  Di Chen; Weijie Guo; Zhaoping Qiu; Qifeng Wang; Yan Li; Linhui Liang; Li Liu; Shenglin Huang; Yingjun Zhao; Xianghuo He
Journal:  Cancer Lett       Date:  2015-04-02       Impact factor: 8.679

Review 3.  Regulatory role of microRNAs in the proliferation and differentiation of adipose-derived stem cells.

Authors:  Doo Yeong Kim; Jong-Hyuk Sung
Journal:  Histol Histopathol       Date:  2016-07-04       Impact factor: 2.303

4.  Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial.

Authors:  David Cella; Viktor Grünwald; Paul Nathan; Justin Doan; Homa Dastani; Fiona Taylor; Bryan Bennett; Michael DeRosa; Scott Berry; Kristine Broglio; Elmer Berghorn; Robert J Motzer
Journal:  Lancet Oncol       Date:  2016-06-06       Impact factor: 41.316

Review 5.  Autophagy in disease: a double-edged sword with therapeutic potential.

Authors:  Wim Martinet; Patrizia Agostinis; Barbara Vanhoecke; Michael Dewaele; Guido R Y De Meyer
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

Review 6.  Autophagy in colorectal cancer: An important switch from physiology to pathology.

Authors:  Florin Burada; Elena Raluca Nicoli; Marius Eugen Ciurea; Daniel Constantin Uscatu; Mihai Ioana; Dan Ionut Gheonea
Journal:  World J Gastrointest Oncol       Date:  2015-11-15

7.  Network organization of the human autophagy system.

Authors:  Christian Behrends; Mathew E Sowa; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2010-06-20       Impact factor: 49.962

8.  Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM.

Authors:  Xia Cheng; Shirui Tan; Feifei Duan; Qingqing Yuan; Qingrong Li; Gang Deng
Journal:  Breast Cancer       Date:  2019-06-06       Impact factor: 4.239

9.  Mitochondrial E3 ubiquitin ligase 1 promotes autophagy flux to suppress the development of clear cell renal cell carcinomas.

Authors:  Yaoji Yuan; Xiezhao Li; Yuyu Xu; Haibo Zhao; Zhengming Su; Dehui Lai; Weiqing Yang; Shuangxing Chen; Yongzhong He; Xun Li; Leyuan Liu; Guibin Xu
Journal:  Cancer Sci       Date:  2019-09-28       Impact factor: 6.716

10.  MicroRNA-30d-5p promotes ovarian granulosa cell apoptosis by targeting Smad2.

Authors:  Miaomiao Yu; Jinxia Liu
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

View more
  5 in total

1.  A six-miRNA signature as a novel biomarker for improving prediction of prognosis and patterns of immune infiltration in hepatocellular carcinoma.

Authors:  Zhitao Chen; Lele Zhang; Chenchen Ding; Kuiwu Ren; Dalong Wan; Shengzhang Lin
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 2.  miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications.

Authors:  Qinlu Zhao; Xin Yuan; Lian Zheng; Miaomiao Xue
Journal:  Front Cell Dev Biol       Date:  2022-01-27

Review 3.  Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects.

Authors:  Ma'mon M Hatmal; Mohammad A I Al-Hatamleh; Amin N Olaimat; Walhan Alshaer; Hanan Hasan; Khaled A Albakri; Enas Alkhafaji; Nada N Issa; Murad A Al-Holy; Salim M Abderrahman; Atiyeh M Abdallah; Rohimah Mohamud
Journal:  Biomedicines       Date:  2022-05-24

4.  miR-30d Inhibition Protects IPEC-J2 Cells Against Clostridium perfringens Beta2 Toxin-Induced Inflammatory Injury.

Authors:  Kaihui Xie; Qiaoli Yang; Zunqiang Yan; Xiaoli Gao; Xiaoyu Huang; Pengfei Wang; Juanli Zhang; Jiaojiao Yang; Jie Li; Shuangbao Gun
Journal:  Front Vet Sci       Date:  2022-06-21

5.  Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

Authors:  Przemysław A Stempor; Dror Avni; Raya Leibowitz; Yechezkel Sidi; Maria Stępień; Tomasz Dzieciątkowski; Paula Dobosz
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.